Svastia
Cambridge, United Kingdom · Founded 2019
- Headquarters
- Cambridge
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- svastia.ai
- Last Round
- SeedJan 2019
- Rounds
- 2
About
Developer of a clinical-genomic platform intended to improve people's lives through precision medicines. The company's platform provides multi-omic analytics workflows and access to novel clinical genomic data to accelerate biomarker discovery and validation, enabling doctors to select the right therapy for patients or refer them to the right clinical trials using their genetic profiles.
Summary
Svastia is a Healthcare company based in Cambridge, United Kingdom, founded in 2019. Its most recent funding was a Seed round in Jan 2019. Investors include Stevenage Bioscience Catalyst and 500 Global.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...